A Rapid Guidance Process for the Development of an Anticoagulation Protocol in the COVID-19 Pandemic

Area of Science:

• Health Systems Science
• Infectious Diseases
• Critical Care Medicine

Background:

• The COVID-19 pandemic presented unprecedented challenges to healthcare systems globally.
• Standardizing patient care was difficult due to the lack of high-quality data during the pandemic's early stages.
• Preliminary evidence suggested hypercoagulability as a key factor in COVID-19, necessitating aggressive anticoagulation strategies.

Purpose of the Study:

• To describe the rapid guidance process for developing an anticoagulation protocol for COVID-19.
• To inform other health systems on managing crises with high patient volumes and evolving information.

Main Methods:

• Collected preliminary evidence from multidisciplinary experts within the institution.
• Developed an initial anticoagulation protocol draft based on expert consensus.
• Acquired and analyzed implementation data to revise the protocol iteratively.
• Incorporated higher-quality data in subsequent protocol modifications.

Main Results:

• A dynamic anticoagulation protocol for COVID-19 was rapidly developed and implemented.
• The protocol underwent iterative revisions based on emerging clinical data and expert feedback.
• The process facilitated adaptive management of patient care during a public health crisis.

Conclusions:

• Rapid, data-driven protocol development is crucial for managing novel infectious disease outbreaks.
• Multidisciplinary collaboration and iterative refinement are key to effective healthcare system response.
• This process provides a model for health systems facing similar crises characterized by uncertainty and rapid information flow.